热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse CD45.2 Antibody
产品名称：
FITC anti-mouse CD45.2 Antibody
产品类别：
抗体
产品编号：
109805
产品应用：
109805
[价格]
规格 价格 库存
50µg ￥ 648 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.?

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  2. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  5. Michalova J, et al. 2011. Biol Blood Marrow Transplant. 17:1273. PubMed
  6. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  7. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  8. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  9. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  10. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  11. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  12. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  13. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  14. Burman A, et al. 2007. Blood. 110:1064. PubMed
  15. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  16. Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
  17. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  18. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  19. Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed
  20. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  21. Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed
  22. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  23. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  24. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  25. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  26. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  27. Emg?rd J, et al. 2018. Immunity. 143:419. PubMed
  28. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  29. Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
  30. Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed
  31. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  32. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  33. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  34. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  35. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  36. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  37. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  38. Li J, et al. 2020. Elife. 9:00. PubMed
  39. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  40. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  41. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  42. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  43. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  44. Wan X, et al. 2018. Nature. 560:107. PubMed
  45. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  46. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  47. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  48. Abbott RK, et al. 2018. Immunity. 48:133. PubMed
  49. Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
  50. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  51. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  52. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  53. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  54. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  55. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  56. Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
  57. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  58. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  59. Zhang W, et al. 2022. Nat Methods. 19:759. PubMed
  60. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  61. Burgess M, et al. 2014. Blood. 124:3947. PubMed
  62. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  63. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  64. de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
  65. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  66. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  67. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  68. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  69. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  70. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  71. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  72. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  73. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  74. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  75. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  76. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  77. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  78. Koide S, et al. 2022. iScience. 25:103603. PubMed
  79. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  80. Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed
  81. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  82. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  83. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  84. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  85. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  86. Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed
  87. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  88. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  89. Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
  90. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  91. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  92. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  93. Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
  94. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  95. Hung LY, et al. 2019. J Immunol. 203:511. PubMed
  96. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  97. Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
  98. Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
  99. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  100. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  101. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  102. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
RRID
AB_313442 (BioLegend Cat. No. 109805) AB_313443 (BioLegend Cat. No. 109806)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线